APA

Ruperto N., Quartier P., Wulffraat N., Woo P., Ravelli A., Mouy R., Bader-Meunier B., Vastert S. J., Noseda E., D'Ambrosio D., Lecot J., Chakraborty A., Martini A. & Chioato A. (20120913). A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. : Arthritis and rheumatism.

Chicago

Ruperto Nicolino, Quartier Pierre, Wulffraat Nico, Woo Patricia, Ravelli Angelo, Mouy Richard, Bader-Meunier Brigitte, Vastert Sebastiaan J, Noseda Emanuele, D'Ambrosio Daniele, Lecot Jean, Chakraborty Abhijit, Martini Alberto and Chioato Andrea. 20120913. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. : Arthritis and rheumatism.

Harvard

Ruperto N., Quartier P., Wulffraat N., Woo P., Ravelli A., Mouy R., Bader-Meunier B., Vastert S. J., Noseda E., D'Ambrosio D., Lecot J., Chakraborty A., Martini A. and Chioato A. (20120913). A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. : Arthritis and rheumatism.

MLA

Ruperto Nicolino, Quartier Pierre, Wulffraat Nico, Woo Patricia, Ravelli Angelo, Mouy Richard, Bader-Meunier Brigitte, Vastert Sebastiaan J, Noseda Emanuele, D'Ambrosio Daniele, Lecot Jean, Chakraborty Abhijit, Martini Alberto and Chioato Andrea. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. : Arthritis and rheumatism. 20120913.